key: cord-0760790-h01v3k6g
authors: Saffarian, Zahra; Samii, Rana; Ghanadan, Alireza; Vahidnezhad, Hassan
title: De novo severe pemphigus vulgaris following SARS‐CoV‐2 vaccination with BBIBP‐CorV
date: 2022-03-20
journal: Dermatol Ther
DOI: 10.1111/dth.15448
sha: bbf09679069a27ae7f02a0c1c20b9fd93ce00241
doc_id: 760790
cord_uid: h01v3k6g

nan

1, the components of intraepithelial desmosomes, lead to acantholysis causing blisters and erosions. 1 

Pemphigus Nat Rev Dis Primers

The genetics of pemphigus vulgaris

Skin manifestations in COVID-19 patients: are they indicators for disease severity? A systematic review

Development of severe pemphigus vulgaris following SARS-CoV-2 vaccination with BNT162b2

Development of pemphigus vulgaris after the second dose of the mRNA-1273 SARS-Cov-2 vaccine

Oral pemphigus after COVID-19 vaccination

COVID-19 vaccines and the skin: the landscape of cutaneous vaccine reactions worldwide

Cutaneous findings following COVID-19 vaccination: review of world literature and own experience

Pemphigus trigger factors: special focus on pemphigus vulgaris and pemphigus foliaceus

Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases